Departments of1Neurosurgery and.
2Università Degli Studi Di Torino, Italy.
J Neurosurg. 2023 Sep 15;140(4):909-919. doi: 10.3171/2023.6.JNS222443. Print 2024 Apr 1.
Preoperative grading of nonenhancing motor eloquent gliomas is hampered by a lack of specific imaging surrogates. Tumor grading is crucial for the informed consent discussion before tumor resection. In this paper, the authors hypothesized that navigated transcranial magnetic stimulation (nTMS)-derived metrics could provide significant information to distinguish between high- and low-grade motor eloquent gliomas that present as nonenhancing tumors and therefore contribute to improving patient counseling, timing of treatment, preoperative planning, and intraoperative strategies.
The authors conducted a retrospective single-center cohort study of patients admitted for tumor surgery between January 2018 and April 2022 with a nonenhancing motor eloquent glioma and preoperative bilateral nTMS mapping. nTMS data including resting motor threshold (RMT), interhemispheric RMT ratio (iRMTr), Cortical Excitability Score (CES), area and volume of cortical activation, and motor evoked potential (MEP) characteristics were obtained and integrated with demographic and clinical data.
Thirty patients met the inclusion criteria, and 10 healthy participants were recruited for comparison. Seizures were the most common presenting symptom (25 patients) and WHO grade 3 the most common tumor grade (21 patients). The area and volume of functional cortical activation of both the abductor pollicis brevis and first dorsal interosseous muscles were decreased in healthy participants compared with patients with WHO grade 3 glioma (p < 0.05). An abnormal iRMTr for the lower limbs (16.7% [1/6] WHO grade 2, 76.2% [16/21] WHO grade 3, 100% [3/3] WHO grade 4; p = 0.015) and a higher CES (maximal abnormal CES: 0% [0/6] WHO grade 2, 38% [8/21] WHO grade 3, 66.7% [2/3] WHO grade 4; p = 0.010) were associated with the prediction of high-grade lesions. A total of 7280 MEPs were analyzed. A significant increase in the amplitude and a significant decrease in latency in the MEPs for the first dorsal interosseous and abductor digiti minimi muscles (p < 0.0001) were identified in healthy participants compared with WHO grade 3 glioma patients.
Nonenhancing motor eloquent gliomas have a different impact on both anatomical and functional reorganization of motor areas according to their WHO grading.
由于缺乏特定的影像学替代指标,非增强运动功能区胶质瘤的术前分级受到阻碍。肿瘤分级对于肿瘤切除前的知情同意讨论至关重要。本文作者假设,经颅磁刺激(TMS)衍生的指标可以提供重要信息,以区分表现为非增强肿瘤的高级别和低级别运动功能区胶质瘤,从而有助于改善患者咨询、治疗时机、术前计划和术中策略。
本研究为回顾性单中心队列研究,纳入 2018 年 1 月至 2022 年 4 月间因非增强运动功能区胶质瘤接受肿瘤手术的患者,术前均行双侧 TMS 定位。获取 TMS 数据,包括静息运动阈值(RMT)、半球间 RMT 比值(iRMTr)、皮质兴奋性评分(CES)、皮质激活面积和体积以及运动诱发电位(MEP)特征,并整合患者的人口统计学和临床资料。
30 名患者符合纳入标准,纳入 10 名健康参与者作为对照。癫痫发作是最常见的首发症状(25 例),肿瘤分级以 WHO 3 级最为常见(21 例)。与 WHO 3 级胶质瘤患者相比,健康参与者的拇短展肌和第一骨间背侧肌的功能皮质激活面积和体积均减小(p<0.05)。下肢异常 iRMTr(16.7%[1/6]WHO 2 级,76.2%[16/21]WHO 3 级,100%[3/3]WHO 4 级;p=0.015)和更高的 CES(最大异常 CES:0%[0/6]WHO 2 级,38%[8/21]WHO 3 级,66.7%[2/3]WHO 4 级;p=0.010)与高级别病变的预测相关。共分析了 7280 个 MEP。与 WHO 3 级胶质瘤患者相比,健康参与者的第一骨间背侧肌和拇短展肌的 MEP 振幅显著增加,潜伏期显著缩短(p<0.0001)。
根据 WHO 分级,非增强运动功能区胶质瘤对运动区的解剖和功能重组有不同的影响。